(pdf)
SciELO 
SciELO 
Permalink
Medicina Interna
ISSN 0872-671X
ALVES, Sara Carneiro; SANTOS, José Augusto; RODRIGUES, Catarina Ramos MOURA, Adriana. Evidence of Renin-Angiotensin System Modifiers in the Prevention of Episodic Migraine. []. , 28, 1, pp.52-58. 15--2021. ISSN 0872-671X. https://doi.org/10.24950/r/190/20/1/2021.
:
Migraine is a common and disabling disease. Experimental models suggest an association between renin-angiotensin system and migraine development. This paper aims to review the evidence of angiotensin inhibitors in reducing migraine episodes.
Methods:
We searched for guidelines, systematic reviews, meta-analysis and randomized controlled trials. Level of evidence and strength of recommendation (SOR) attribution were based on Strength of Recommendation Taxonomy (SORT).
Results:
We identified 63 articles, from which we selected eight: four guidelines, two meta-analysis and two systematic review.
Discussion/Conclusion:
Candesartan 16 mg/day may be used as a preventive treatment of episodic migraine (SOR B), in spite of not being recommended as the first line of treatment. Lisinopril also showed some potential. (SOR B)
: Angiotensin-Converting Enzyme Inhibitors; Migraine Disorders/prevention & control.
